Watch for Confusion Between Fiasp and NovoLog

December 2017

Reps will promote the new insulin aspart (Fiasp, FEE-asp) as an "ultrafast-acting" mealtime insulin for adults.

Think of Fiasp as similar to NovoLog. They're both insulin aspart from the same company...except Fiasp has an additive to speed absorption.

You may hear that Fiasp starts working about 5 minutes faster than NovoLog. But this isn't clinically significant most of the time.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote